Ashton Chen to Treatment Outcome
This is a "connection" page, showing publications Ashton Chen has written about Treatment Outcome.
Connection Strength
0.172
-
Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, Lin JJ. Severe intellectual disability is not a contraindication to kidney transplantation in children. Pediatr Transplant. 2017 May; 21(3).
Score: 0.086
-
Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol. 2007 Aug 06; 8:11.
Score: 0.045
-
Kizilbash S, Claes D, Ashoor I, Chen A, Jandeska S, Matar RB, Misurac J, Sherbotie J, Twombley K, Verghese P. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Pediatr Transplant. 2017 May; 21(3).
Score: 0.022
-
Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, Nelson RD, Kiessling SG, Brophy PD, Quiroga A, Seifert ME, Straatmann CE, Mahan JD, Ferris ME, Troost JP, Gipson DS. Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2016 Mar; 31(3):465-72.
Score: 0.020